FDA Warning Letter: Biosensors Interventional Technologies Pte Ltd
type: Action
additional type: https://schema.org/RegulationAction
start time: 2023-07-25
description: Medical Device Reporting/Misbranded. Issued by FDA OHT2: Office of Cardiovascular Devices, Office of Product Evaluation and Quality on 2023-07-21.
agent: FDA OHT2: Office of Cardiovascular Devices, Office of Product Evaluation and Quality
object: Biosensors Interventional Technologies Pte Ltd
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
source organization: U.S. Food and Drug Administration
publisher: AI Analytics

PropertyValue
property ID: FDA Warning Letter ID
value: 1a7909cf955ddb76

AI Analytics
type: Organization